Marapharm announced today that it has purchased 1,500,000 units of Veritas Pharma Inc. at a purchase price of $0.28 per unit
Marijuana Investing
Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery
Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils.
Grey Cloak Tech, Inc. (GRCK) Announces Cancellation of Reverse Stock Split
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
Cronos Group Inc. Announces $15 Million Bought Deal
Cronos Group Inc. (TSX VENTURE: MJN) is pleased to announce that it has entered into a letter of engagement with PI Financial Corp. ("PI") as sole lead underwriter.
Marijuana Company of America (MCOA) Stands Out among Cannabis and Hemp Industry Innovators
Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model.
EVIO, Inc. (EVIO) Expands Testing Capabilities at Yuba City Laboratory
EVIO, Inc. this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California.
India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided compelling in vitro data
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.
Canopy Growth Applauds Action by TSX to Confirm That Listed Companies Should Not be Engaging in Federally Illegal US Cannabis Activities
TSX Staff Notice on Marijuana Validates Canopy's Longstanding Market Strategy to Protect Investors by Conducting Business Only Where it is Federally Legal to Do So; Should Bring Clarity and Relief to Investors Seeking to Participate in Listed and Compliant Cannabis Companies
InMed Provides Updates On Cannabinoid-Based Drug Therapies For The Treatment Of Pain
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announced today additional pre-clinical results in the development of INM-405 for the treatment of pain.
PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter
PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August.
Global Payout, Inc. (GOHE) Subsidiary Makes Successful Showing at 2017 Southwest Cannabis Conference and Expo
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, in addition to its newly-acquired marketing and publishing entity, PotSaver, made a successful showing at last week’s Southwest Cannabis Conference and Expo in Phoenix, Arizona.
Skinvisible, Inc. (SKVI) Has Been Delivering its Patented Polymer Technology to Pharmaceuticals & Cosmeceuticals for Close to Two Decades
Invisicare is a patented polymer delivery system that improves the delivery of topically applied skin care products, thereby enhancing the efficacy of the active ingredients.
Taking Stock of InMed - InMed President and CEO Eric Adams Sits Down For Two In-Depth Interviews
InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.